Belvedere Trading LLC Protagonist Therapeutics, Inc Put Options Transaction History

Belvedere Trading LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 30, 2024	SELL	$33.72 - $47.33 $77,556 - $108,859	-2,300 Reduced 92.0%	200 $8,000
Q2 2024 Nov 01, 2024	BUY	$24.66 - $34.8 $56,718 - $80,040	2,300 Added 1150.0%	2,500 $86,000
Q2 2024 Aug 09, 2024	BUY	$24.66 - $34.8 $61,650 - $87,000	2,500 New	2,500 $86,000
Q2 2023 Aug 08, 2023	SELL	$18.02 - $29.36 $54,060 - $88,080	-3,000 Reduced 61.22%	1,900 $52,000
Q1 2023 May 15, 2023	BUY	$10.78 - $25.38 $52,822 - $124,362	4,900 New	4,900 $112,000
Q2 2022 Jul 21, 2022	BUY	$7.06 - $25.52 $23,298 - $84,216	3,300 Added 1100.0%	3,600 $37,000
Q3 2021 Oct 19, 2021	BUY	$12.95 - $49.69 $3,885 - $14,907	300 New	300 $9,000

248

56.7M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.93B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.